Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

MWN109 2

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 2 TRIAL

Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity

ClinicalTrials.gov

Phase 2 registry record with no reported results; study is active but not yet recruiting or completed, describing a planned 24-week intervention in 71 participants.

PreliminaryMWN109 1 Overweight , Obesity Shanghai Minwei Biotechnology Co.

Reported

Planned enrollment71

PhasePhase 2

Primary outcome measurePercentage change in body weight compared t…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support